Relx (NYSE:RELX) Reaches New 52-Week High at $34.02

Relx Plc (NYSE:RELX – Get Rating)’s stock price reached a new 52-week high on Friday . The company traded as high as $34.02 and last traded at $34.00, with a volume of 71633 shares changing hands. The stock had previously closed at $33.49.

Wall Street Analysts Forecast Growth

RELX has been the subject of a number of recent analyst reports. StockNews.com initiated coverage on Relx in a research report on Thursday, May 18th. They set a “hold” rating for the company. JPMorgan Chase & Co. upped their target price on Relx from GBX 2,840 ($35.54) to GBX 3,100 ($38.79) in a research report on Friday, April 14th.

Get Relx alerts:

Relx Stock Up 1.6 %

The company has a current ratio of 0.59, a quick ratio of 0.53 and a debt-to-equity ratio of 1.56. The business has a fifty day moving average price of $31.96 and a 200 day moving average price of $30.47.

Hedge Funds Weigh In On Relx

A number of institutional investors have recently modified their holdings of RELX. Jane Street Group LLC acquired a new position in shares of Relx during the 2nd quarter worth $23,448,000. Clearbridge Investments LLC increased its holdings in Relx by 53.2% in the 4th quarter. Clearbridge Investments LLC now owns 2,359,923 shares of the technology company’s stock worth $65,417,000 after purchasing an additional 819,697 shares in the last quarter. Optiver Holding B.V. acquired a new position in Relx in the 1st quarter worth about $17,835,000. Norges Bank acquired a new position in Relx in the 4th quarter worth about $14,608,000. Finally, Arrowstreet Capital Limited Partnership increased its holdings in Relx by 36.7% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 1,378,055 shares of the technology company’s stock worth $42,858,000 after purchasing an additional 370,016 shares in the last quarter. Institutional investors and hedge funds own 3.41% of the company’s stock.

Relx Company Profile

(Get Rating)

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

Further Reading

• Get a free copy of the StockNews.com research report on Relx (RELX)
• MarketBeat Week in Review – 6/12 – 6/16
• Micron Building Goodwill In Asia, Near $2 Billion Investment
• Is Twilio On The Verge Of A Comeback?
• Broadcom: All-Time Highs But Still Good Value
• Leverage AI And Build A Fortress Portfolio With Adobe

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.